LivaNova PLC (LIVN) Upgraded at ValuEngine
ValuEngine upgraded shares of LivaNova PLC (NASDAQ:LIVN) from a hold rating to a buy rating in a report released on Thursday morning.
Several other research firms also recently issued reports on LIVN. WBB Securities downgraded LivaNova PLC from a hold rating to a sell rating and set a $50.00 price objective on the stock. in a report on Tuesday, August 15th. BidaskClub downgraded LivaNova PLC from a strong-buy rating to a buy rating in a report on Monday, July 24th. Piper Jaffray Companies reaffirmed an overweight rating and set a $75.00 price objective on shares of LivaNova PLC in a report on Tuesday, September 12th. Needham & Company LLC started coverage on LivaNova PLC in a report on Wednesday, August 23rd. They set a hold rating on the stock. Finally, Canaccord Genuity reaffirmed a hold rating and set a $71.00 price objective on shares of LivaNova PLC in a report on Wednesday, September 20th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of Hold and an average price target of $76.00.
LivaNova PLC (NASDAQ:LIVN) traded down $1.03 during trading hours on Thursday, reaching $80.73. The company’s stock had a trading volume of 322,086 shares, compared to its average volume of 426,465. The company has a current ratio of 2.03, a quick ratio of 1.42 and a debt-to-equity ratio of 0.04. The stock has a market cap of $3,941.78, a price-to-earnings ratio of 23.56, a P/E/G ratio of 2.46 and a beta of 0.52.
LivaNova PLC (NASDAQ:LIVN) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.76 by $0.17. LivaNova PLC had a return on equity of 9.33% and a net margin of 4.63%. The firm had revenue of $309.70 million for the quarter, compared to the consensus estimate of $301.22 million. During the same quarter in the prior year, the business earned $0.78 EPS. The business’s revenue for the quarter was up 4.9% compared to the same quarter last year. equities analysts predict that LivaNova PLC will post 3.33 earnings per share for the current fiscal year.
In other LivaNova PLC news, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $60.76, for a total transaction of $60,760.00. Following the completion of the sale, the director now owns 58,296 shares in the company, valued at approximately $3,542,064.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold a total of 3,000 shares of company stock valued at $203,890 in the last quarter. Corporate insiders own 0.28% of the company’s stock.
Institutional investors have recently modified their holdings of the business. PNC Financial Services Group Inc. raised its position in shares of LivaNova PLC by 9.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after acquiring an additional 153 shares during the last quarter. Riverhead Capital Management LLC raised its position in shares of LivaNova PLC by 76.3% during the 2nd quarter. Riverhead Capital Management LLC now owns 1,763 shares of the company’s stock valued at $108,000 after acquiring an additional 763 shares during the last quarter. Exane Derivatives raised its position in shares of LivaNova PLC by 814.8% during the 2nd quarter. Exane Derivatives now owns 3,156 shares of the company’s stock valued at $158,000 after acquiring an additional 2,811 shares during the last quarter. Teacher Retirement System of Texas bought a new stake in shares of LivaNova PLC during the 2nd quarter valued at $204,000. Finally, LS Investment Advisors LLC raised its position in shares of LivaNova PLC by 14.5% during the 2nd quarter. LS Investment Advisors LLC now owns 3,449 shares of the company’s stock valued at $211,000 after acquiring an additional 436 shares during the last quarter. Institutional investors own 81.69% of the company’s stock.
LivaNova PLC Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.